Reliable AI for Healthcare’s Most Critical Decisions Scale builds AI that clinicians can trust, embedded inside your workflows and evaluated continuously so it stays accountable for outcomes. AI Systems for Every Clinical Decision Synthesize clinical history to reduce delays Consolidates a patient's full history to recommend the right labs, imaging, and prescriptions, so clinicians spend less time piecing together charts. Review clinical order with AI-powered assistance MRN DERM-2024-0089 · DOB 1961-11-04 · 62 Male · Medicare Advantage Wide Excisional Biopsy (Urgent) — Complete with Sentinel Lymph Node Mapping ORDERING PROVIDER Dr. Rachel Torres, MD — Primary Care REQUESTED WINDOW Within 5 days — URGENT (regional lymphadenopathy + elevated LDH + worsening systemic symptoms) Urgent wide excisional biopsy with sentinel lymph node mapping for: (1) 6-week history of a rapidly enlarging, irregular pigmented lesion on the back with color variation, now 14mm (ABCDE-positive: Asymmetry, Border irregularity, Color variation, Diameter, Evolving); (2) 12 lb unintentional weight loss over 10 weeks; (3) new ulceration and intermittent bleeding from the lesion (2 weeks); (4) new palpable satellite nodule adjacent to the primary lesion; (5) regional ultrasound showing a 1.8 cm left axillary lymph node with loss of normal fatty hilum — radiologist recommends histopathological correlation; (6) LDH elevated at 285 U/L; (7) Strong family history — father melanoma age 55, maternal uncle melanoma age 62. Prior incomplete shave biopsy (community clinic, 2022) — insufficient depth, Breslow staging not possible. Tertiary dermatologic oncology center required for wide excision with sentinel lymph node biopsy given anatomical/staging complexity. DIAGNOSES (ICD-10) L98.9 — Disorder of the skin and subcutaneous tissue, unspecified (evolving pigmented lesion); R59.0 — Localized enlarged lymph nodes; R63.4 — Abnormal weight loss; Z80.8 — Family history of malignant neoplasm of other organs (melanoma); D48.5 — Neoplasm of uncertain behavior, skin (rule out — biopsy pending); R79.89 — Other specified abnormal findings of blood chemistry (elevated LDH); N18.3 — Chronic kidney disease, Stage 3a (eGFR 58); E11.9 — Type 2 diabetes mellitus without complications (newly diagnosed). more minutes with every patient

Matthew R. Callstrom, M.D., Ph.D. Built on Scale’s reliability layer for healthcare Forward-deployed clinical and engineering teams Applied AI engineers and clinical informaticists embedded inside your health system, accountable for outcomes, not just delivery. Evaluations compound clinical value Frontier-trained evals and clinical domain experts encode institutional knowledge to continually improve every agent's accuracy and safety. Deploy anywhere, on your terms Scale connects to your existing EHR, imaging, and clinical data systems. No migration required, and it works with any model. Fuel Your AI Strategy Rad Agent Multi-Agent Radiology Solution Scalable Infrastructure for Enterprise-Ready AI Agents Mayo Clinic + Scale: Reliable AI for Better Healthcare Built for healthcare trust and privacy Meets the security, safety, and clinical standards required for healthcare. The future of healthcare starts here